BROSSARD, Quebec, May 23, 2025 (GLOBE NEWSWIRE) -- Diagnos Inc. (“DIAGNOS” or the “Corporation”) (TSX Venture: ADK, OTCQB: DGNOF, FWB: 4D4A), a pioneer in early detection of critical health issues using advanced technology based on Artificial Intelligence (AI), announces the engagement of Allele Capital Partners, LLC (“Allele”) to provide capital markets advisory and social media services to the Corporation. As per the agreement signed between Allele and DIAGNOS, Allele is entitled to a monthly compensation ...